A detailed history of Jump Financial, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Jump Financial, LLC holds 2,969 shares of VRTX stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,969
Previous 15,006 80.21%
Holding current value
$1.34 Million
Previous $7.03 Million 80.38%
% of portfolio
0.03%
Previous 0.15%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $5.54 Million - $6.09 Million
-12,037 Reduced 80.21%
2,969 $1.38 Million
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $2.51 Million - $3.11 Million
6,401 Added 74.39%
15,006 $7.03 Million
Q1 2024

May 13, 2024

SELL
$407.69 - $446.08 $8.98 Million - $9.82 Million
-22,023 Reduced 71.9%
8,605 $3.6 Million
Q4 2023

Oct 21, 2024

BUY
$343.0 - $410.68 $6.92 Million - $8.28 Million
20,163 Added 192.67%
30,628 $12.5 Million
Q4 2023

Feb 07, 2024

BUY
$343.0 - $410.68 $6.92 Million - $8.28 Million
20,163 Added 192.67%
30,628 $12.5 Million
Q3 2023

Oct 21, 2024

BUY
$338.18 - $362.46 $1.08 Million - $1.15 Million
3,180 Added 43.65%
10,465 $3.64 Million
Q3 2023

Nov 07, 2023

BUY
$338.18 - $362.46 $1.08 Million - $1.15 Million
3,180 Added 43.65%
10,465 $3.64 Million
Q2 2023

Oct 21, 2024

SELL
$314.42 - $351.91 $2.43 Million - $2.72 Million
-7,721 Reduced 51.45%
7,285 $2.56 Million
Q2 2023

Aug 07, 2023

BUY
$314.42 - $351.91 $2.29 Million - $2.56 Million
7,285 New
7,285 $2.56 Million
Q3 2022

Nov 07, 2022

BUY
$273.83 - $305.53 $524,932 - $585,701
1,917 New
1,917 $555,000
Q2 2022

Aug 09, 2022

SELL
$234.96 - $292.55 $245,533 - $305,714
-1,045 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$221.42 - $260.97 $3.79 Million - $4.47 Million
-17,122 Reduced 94.25%
1,045 $273,000
Q4 2021

Feb 10, 2022

BUY
$177.01 - $223.45 $3.22 Million - $4.06 Million
18,167 New
18,167 $3.99 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $324,732 - $382,945
-1,732 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $358,558 - $417,948
1,732 New
1,732 $372,000
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $260,625 - $347,597
-1,259 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $321,863 - $381,602
1,259 New
1,259 $343,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.